KARISSA PRIESMEYER: Open Payments
NPI 1740906346 · EL CAMPO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 68 payments from 13 companies in 2025. Trend: 2023 $1,071 · 2024 $1,133 · 2025 $1,003
Food & beverage: $921Education: $82
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $241 |
| Galderma Laboratories, L.P. | 14 | $178 |
| ABBVIE INC. | 17 | $160 |
| Regeneron Healthcare Solutions, Inc. | 3 | $90 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| GENZYME CORPORATION | 2 | $50 |
| UCB, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $48 |
| Organon LLC | 5 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, RINVOQ, SKYRIZI, COSENTYX, Bimzelx, TALTZ.
Industry payments across TX — which companies pay providers there.
